ArticleNeurology(R) neuroimmunology & neuroinflammation2017

α4-integrin receptor desaturation and disease activity return after natalizumab cessation.

Tobias Derfuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.